The Science Behind CBD, CBG, CBN, CBC, THC, and Their Effects on the Body

Cannabinoids are naturally occurring compounds found in the cannabis plant, which interact with the human body's endocannabinoid system. The most well-known cannabinoids are

 CBD (cannabidiol), CBG (cannabigerol), CBN (cannabinol), CBC (cannabichromene), and THC (tetrahydrocannabinol). 

Each of these cannabinoids has unique properties and effects on the body.

 CBD (Cannabidiol)

CBD is a non-psychoactive cannabinoid that has gained popularity for its potential health benefits. It is known to interact with the body's endocannabinoid system, particularly the CB1 and CB2 receptors, which play a role in regulating various physiological processes, such as pain, inflammation, and mood. CBD has been shown to have antioxidant and anti-inflammatory properties, which may help alleviate chronic pain, anxiety, and depression. 

 CBG (Cannabigerol)

CBG is another non-psychoactive cannabinoid that is gaining attention for its potential therapeutic effects. It works by binding to both CB1 and CB2 receptors, where it is thought to strengthen the function of anandamide, a neurotransmitter that plays a role in enhancing pleasure, motivation, regulating appetite, sleep, and alleviating pain. Preclinical studies have shown that CBG may help reduce intraocular pressure, possess antioxidant, anti-inflammatory, and anti-tumoral activities. 

CBN (Cannabinol)

CBN is a mildly psychoactive cannabinoid that is produced as THC degrades. It binds with CB2 receptors in the body's endocannabinoid system, which are mostly associated with immune system regulation. CBN has been shown to have sedative effects, particularly when combined with THC, and may help improve sleep quality. It also has potential anti-inflammatory and pain-relieving properties .

 CBC (Cannabichromene)

CBC is a non-psychoactive cannabinoid that has been found to have potential anti-inflammatory and pain-relieving effects. It may affect the receptor involved in pain detection and regulating the body's heat. CBC has also been shown to work in tandem with other cannabinoids, such as THC, CBD, CBG, and CBN, to boost their therapeutic effects through the entourage effect. 

 THC (Tetrahydrocannabinol) 

THC legally and scientifically known as  "Delta 9 THC" is the primary psychoactive compound in cannabis, responsible for the "high" associated with marijuana use. It acts on specific brain cell receptors that ordinarily react to natural THC-like chemicals, affecting areas that influence pleasure, memory, thinking, concentration, movement, coordination, and sensory and time perception. THC also disrupts the functioning of the cerebellum and basal ganglia, which regulate balance, posture, coordination, and reaction time.

The amount or percentage of Delta 9 THC is what legally dictates whether a plant or product is hemp or marijuana (preferably known as medical/recreational cannabis)
According to the 2018 Federal Farm Bill : If a product or plant contains 0.3% or less Delta 9 THC by weight or volume it is considered hemp and therefore legal. This also includes the slight margin of error contained within part 990.1 of the Federal Domestic Hemp Production Program.

All of our products are hemp in the field and hemp as final products

Authority: 7 U.S.C. 1639o note, 1639p, 1639q, 1639r.Source: 86 FR 5680, Jan. 19, 2021, unless otherwise noted.

Acceptable hemp THC level. When a laboratory tests a sample, it must report the total delta-9 tetrahydrocannabinol content concentration level on a dry weight basis and the measurement of uncertainty. The acceptable hemp THC level for the purpose of compliance with the requirements of State or Tribal hemp plans or the USDA hemp plan is when the application of the measurement of uncertainty to the reported total delta-9 tetrahydrocannabinol content concentration level on a dry weight basis produces a distribution or range that includes 0.3 percent or less. For example, if the reported total delta-9 tetrahydrocannabinol content concentration level on a dry weight basis is 0.35 percent and the measurement of uncertainty is ±0.06 percent, the measured total delta-9 tetrahydrocannabinol content concentration level on a dry weight basis for this sample ranges from 0.29 percent to 0.41 percent. Because 0.3 percent is within the distribution or range, the sample is within the acceptable hemp THC level for the purpose of plan compliance. This definition of “acceptable hemp THC level” affects neither the statutory definition of hemp, 7 U.S.C. 1639o(1), in the 2018 Farm Bill nor the definition of “marihuana,” 21 U.S.C. 802(16), in the CSA.